Immunogenicity and safety of Cervarix HPV-16/18 AS04-adjuvant vaccine against HPV induced cervical cancer in women (15+ years). UCC Student Medical Journal, [S. l.], v. 3, p. 50–61, 2024. DOI: 10.33178/SMJ.2023.1.5. Disponível em: https://journals.ucc.ie/index.php/smj/article/view/4323.. Acesso em: 6 apr. 2025.